A longer look at COVID-19 and neuropsychiatric outcomes, Lancet Psychiatry

Early in the pandemic, concerns were raised about the potential for serious and widespread neurological and psychiatric adverse outcomes following COVID-19, on the basis of a systematic review of observational studies done in patients infected during previous coronavirus epidemics. Interpretation was hampered by the absence of a comparison group of individuals who had similar infections. The first large-scale attempt to redress this issue was published by Maxime Taquet and colleagues who found, using real-world data, that a first psychiatric diagnosis was more common in patients with COVID-19 in the 14 –90 days after SARS-CoV-2 infection than in those with several other acute illnesses. In The Lancet Psychiatry, Taquet and colleagues expand on this finding by estimating incidence rates and relative risks of 14 neurological and psychiatric diagnoses in patients in the 6 months after a COVID-19 di agnosis.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news